Planning commissioners delay decision on AEGIS medication unit at Oro Dam Boulevard amid location concerns

The Oroville City Planning Commission on Tuesday continued consideration of a use-permit application from AEGIS to open a medication unit at 1121 Oro Dam Boulevard, moving the item to the commission’s next meeting for further review.

The item drew a staff recommendation to approve and a detailed presentation from the applicant about operations, but several commissioners and a member of the public said the proposed site — at a former retail building in a busy commercial strip — raises neighborhood and perception concerns.

West Urban, City Planner, told the commission the proposal would convert roughly half of a 5,500-square-foot former retail building into medical offices on a 68,000-square-foot parcel. He said the applicant has agreed to restripe the lot, remove two conex boxes from the rear of the property, update landscaping, secure the trash enclosure and create a clear path of travel to the recently constructed Caltrans sidewalk. Urban said the building sits more than 500 feet from the nearest schools or residences, which meets a siting requirement for outpatient treatment centers; he added that staff recommended approval.

Moises Alcantara, an AEGIS representative who spoke to the commission, and Rebecca Mitchell, identified herself as Rebecca “Becca” Mitchell, Regional Vice President for AEGIS for Northern California, described how the medication unit would operate as an adjunct to the Chico clinic. Mitchell said Chico serves about 514 patients and that roughly 90 of those patients have Oroville addresses and currently travel to Chico for medication. She said the Oroville medication unit would be primarily operational from about 5 a.m. to 1 p.m., seven days a week, employ about 15–20 staff and use security cameras and other measures to minimize community impacts. Mitchell said AEGIS provides methadone and buprenorphine treatment, weekly counseling and monthly random drug testing, and that many patients qualify for take-home medication when stable.

Marsha Henderson, an Oroville resident who addressed the commission during public comment, said she supports treatment but opposed the specific location at the mall on Oro Dam Boulevard. "I just don't feel like the rest of the public is going to feel welcoming," Henderson said, adding that the site is not near other medical services and that the boulevard is a busy corridor where people without vehicles would have to walk a long sidewalk to reach the clinic.

Commissioners acknowledged the clinic is needed in Oroville but repeatedly cited the site as the primary concern. One commissioner noted an existing methadone clinic on Montgomery Street that, according to staff remarks, has operated quietly and generated little enforcement activity. Daniel Friedman, who identified himself as a representative for the applicant, urged commissioners to judge the application by the use-permit findings in the packet and noted the practical difficulty of finding a site that meets every preferred criterion.

No formal motion to approve was made. After discussion about public notice, potential community reaction and the option to gather additional information (including police or code-enforcement data from other jurisdictions), the commission reached a general consensus to continue the item to the next Planning Commission meeting on July 24, 2025, for a fuller discussion and to allow staff and commissioners time to gather more information for public outreach.

The file in the commission packet referenced specific findings (noted on page 7) and a condition (condition 13, page 20) that allows the commission to revoke or modify a use permit at its discretion.

If the commission later votes to approve the use permit, staff and the applicant have already noted several operational commitments — restrained hours, security measures, improved landscaping and removal of onsite storage containers — that would be reflected in conditions of approval.

The commission’s continued review leaves the application without a decision. Staff will return the matter at the next meeting with any additional information requested by commissioners; the applicant said it is prepared to answer follow-up questions and provide evidence from other AEGIS locations about operational impacts.